Related Articles
Results of cytology and high‑risk human papillomavirus testing in females with cervical adenocarcinoma in situ
Epidemiological study of high‑risk human papillomavirus infection in subjects with abnormal cytological findings in cervical cancer screening
Production and characterization of a monoclonal antibody (MSN-3) for uterine endometrial and endocervical adenocarcinoma
Intestinal‑type mucinous carcinoma of the endometrium showing a polypoidal exophytic form: A case report
Predictors of treatment failure for adenocarcinoma in situ of the uterine cervix: Up to 14 years of recorded follow‑up